Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Powis

Showing results (11-20 of 261) with videos related to

Pageof 27
Sort By:
The Journal of Physiology|October 1, 1973
Binding of catecholamines to connective tissue and the effect upon the responses of blood vessels to noradrenaline and to nerve stimulationG Powis
Tumori|April 30, 1994
Recent advances in the development of anticancer drugs that act against signalling pathwaysG Powis
Drug Metabolism Reviews|January 1, 1989
The use of human liver for foreign compound metabolism and toxicity studiesG Powis
Trends in Pharmacological Sciences|May 1, 1991
Signalling targets for anticancer drug developmentG Powis
Biochemical Pharmacology|January 1, 1979
Hepatic microsomal metabolism of epinephrine and adrenochrome by superoxide-dependent and -independent pathwaysG Powis
The Journal of Pharmacy and Pharmacology|May 1, 1974
Effect of serum albumin upon the response of the rat isolated superfused anococcygeus muscle to catecholamines and to nerve stimulationG Powis
Comparative Biochemistry and Physiology. C: Comparative Pharmacology|December 1, 1975
The binding of catecholamines to the serum proteins of the rat and the domestic fowlG Powis
Cancer Chemotherapy and Pharmacology|January 1, 1985
Anticancer drug pharmacodynamicsG Powis
Journal of Chromatography|December 11, 1981
Reversed-phase high-performance liquid chromatographic assay for the antineoplastic agent 9,10-anthracenedicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl hydrazone) dihydrochlorideG Powis
Pharmacology & Therapeutics|April 1, 1994
Signalling pathways as targets for anticancer drug developmentG Powis
Pageof 27

Showing results (11-20 of 261) with videos related to

Sort By:
Pageof 27
The Journal of Physiology|October 1, 1973
Binding of catecholamines to connective tissue and the effect upon the responses of blood vessels to noradrenaline and to nerve stimulationG Powis
Tumori|April 30, 1994
Recent advances in the development of anticancer drugs that act against signalling pathwaysG Powis
Drug Metabolism Reviews|January 1, 1989
The use of human liver for foreign compound metabolism and toxicity studiesG Powis
Trends in Pharmacological Sciences|May 1, 1991
Signalling targets for anticancer drug developmentG Powis
Biochemical Pharmacology|January 1, 1979
Hepatic microsomal metabolism of epinephrine and adrenochrome by superoxide-dependent and -independent pathwaysG Powis
The Journal of Pharmacy and Pharmacology|May 1, 1974
Effect of serum albumin upon the response of the rat isolated superfused anococcygeus muscle to catecholamines and to nerve stimulationG Powis
Comparative Biochemistry and Physiology. C: Comparative Pharmacology|December 1, 1975
The binding of catecholamines to the serum proteins of the rat and the domestic fowlG Powis
Cancer Chemotherapy and Pharmacology|January 1, 1985
Anticancer drug pharmacodynamicsG Powis
Journal of Chromatography|December 11, 1981
Reversed-phase high-performance liquid chromatographic assay for the antineoplastic agent 9,10-anthracenedicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl hydrazone) dihydrochlorideG Powis
Pharmacology & Therapeutics|April 1, 1994
Signalling pathways as targets for anticancer drug developmentG Powis
Pageof 27